Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
Okay, the user is posing a high-stakes scenario as the CEO of a pharmaceutical company facing a serious drug safety issue. This is clearly a crisis management test that requires balancing multiple competing priorities. Hmm, the core tension here is between immediate patient safety versus corporate survival.Read the full answer